Immunovant, Inc. (IMVT) Misses Q4 EPS by 13c

Immunovant, Inc. (NASDAQ: IMVT) reported Q4 EPS of ($0.73), $0.13 worse than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.

You May Also Be Interested In

• China semiconductor equipment imports grow 9% in July, Barclays comments
• Marti Technologies (MRT) PT Raised to $6 at Benchmark on Stronger Growth, Improved Earnings Visibility
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance